Average Co-Inventor Count = 5.88
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (12 from 4,942 patents)
2. F. Hoffmann-la Roche Ag (168 patents)
12 patents:
1. 12421211 - Heterocyclic compounds
2. 11858912 - Heterocyclic compounds
3. 11447489 - Dihydropyrimidinylthiazole for the treatment and prophylaxis of hepatitis B virus infection
4. 11191775 - PAPD5 and PAPD7 inhibitors for treating a hepatitis B infection
5. 11104674 - Tetrahydropyridopyrimidines for the treatment of HBV infection
6. 10968218 - Tetrahydropyridopyrimidines for the treatment and prophylaxis of hepatitis B virus infection
7. 10150740 - 6,7-dihydropyrido[2,1-A]phthalazin-2-ones for the treatment and prophylaxis of hepatitis B virus infection
8. 10053461 - Tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection
9. 9949966 - Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
10. 9845322 - Tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis B virus infection
11. 9637485 - 6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection
12. 9458153 - Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection